Tiger Brokers

Bausch + Lomb Reports Q3 Revenue of $1.28 Billion

Reuters
Oct 29, 2025
Bausch + Lomb Reports Q3 Revenue of $1.28 Billion

Bausch + Lomb Corporation reported its third-quarter 2025 financial results. The company recorded a net loss attributable to Bausch + Lomb Corporation of $28.0 million for the third quarter of 2025, compared to net income of $4.0 million in the same period of 2024, reflecting an unfavorable change of $32.0 million primarily due to an increase in income tax provision. Adjusted net income attributable to Bausch + Lomb Corporation (non-GAAP) was $66.0 million, up from $46.0 million in the prior year period. Cash flow from operations for the third quarter of 2025 was $137.0 million, down from $154.0 million in the third quarter of 2024, a decrease of $17.0 million, mainly due to business transformation payments. GAAP earnings per share $(EPS)$ basic and diluted attributable to Bausch + Lomb Corporation was ($0.08) for the third quarter of 2025, compared to $0.01 for the same period in 2024. Adjusted EPS (non-GAAP) was $0.18, up from $0.13 in the prior year period. Adjusted EPS excluding Acquired IPR&D (non-GAAP) was $0.18, compared to $0.17 in the third quarter of 2024. Adjusted EBITDA (non-GAAP) was $243.0 million for the third quarter of 2025, up from $212.0 million in the third quarter of 2024. Adjusted EBITDA excluding Acquired IPR&D (non-GAAP) was $243.0 million, compared to $227.0 million in the same period of 2024. During the period, the company reported broad-based revenue growth across all segments, led by Pharmaceuticals and Vision Care. It also expanded its leadership in dry eye with growth in MIEBO, and regained momentum in premium IOLs with growth in enVista and LUX platforms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251029243438) on October 29, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10